Board of directors (11)
Directors with a Section 16 filing in the last 13 months. “Since” is the first filing as a director; SEC data sets start in 2016.
Executive officers (8)
Company facts
- Chair
- —
- In S&P 500 since
- May 2023
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC industry
- Ordnance & Accessories, (No Vehicles/Guided Missiles)
- SEC filings
- EDGAR
Connections to other S&P 500 companies
Current directors and officers who also hold a role at another S&P 500 company.
Major holders (5% or more)
Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.
No 5% holder filings parsed yet for this company.
Insider trades
Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2026 | Isaiah Fields Chief Legal Officer | Sale | 1,017 | $480.45 | $489K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 749 | $507.48 | $380K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 1,774 | $508.45 | $902K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 1,319 | $509.32 | $672K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 71 | $501.99 | $36K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 410 | $503.74 | $207K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 1,104 | $505.59 | $558K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 744 | $506.48 | $377K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 1,348 | $510.59 | $688K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 1,251 | $511.43 | $640K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 1,033 | $512.70 | $530K |
| Sep 8, 2026 | Patrick W. Smith CHIEF EXECUTIVE OFFICER | Sale | 197 | $513.38 | $101K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 347 | $561.08 | $195K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 373 | $562.27 | $210K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 359 | $563.50 | $202K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 1,232 | $564.47 | $695K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 661 | $565.37 | $374K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 188 | $566.32 | $106K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 193 | $567.53 | $110K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 1,684 | $568.95 | $958K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 898 | $569.70 | $512K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 643 | $570.94 | $367K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 677 | $571.98 | $387K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 314 | $573.37 | $180K |
| Aug 31, 2026 | Joshua Isner PRESIDENT | Sale | 283 | $574.67 | $163K |
Board and executive changes
Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.
- Jul 10, 2026
On July 8, 2026, Vivek Mohindra and Eiso Kant were appointed to the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) effective immediately. The Board also appointed Mr. Mohindra to serve on the Audit Committee and Compensation Committee, and appointed Mr. Kant to serve as a non-voting observer of the Mergers & Acquisitions and Capital Structure Committee of the Board, in each case commencing concurrently with their Board service. Messrs. Mohindra and Kant are independent directors, each with an initial term expiring at the Company’s 2027 annual meeting of stockholders. In connection with their appointments, each of Mr. Mohindra and Mr. Kant was appointed to fill an existing vacancy on the Board. Compensation for each of Messrs.
Read the 8-K filing - Apr 10, 2026
On April 6, 2026, Matthew McBrady notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that he will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”). Mr. McBrady will continue to serve as a director until his term expires at the Annual Meeting. Mr. McBrady’s decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Board greatly appreciates Mr. McBrady’s deep commitment, leadership and many contributions to the Board and to the Company’s growth and progress during his years of service.
Read the 8-K filing - Mar 11, 2026
On March 5, 2026, Julie Anne Cullivan notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that she will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”). Ms. Cullivan will continue to serve as a director until her term expires at the Annual Meeting. Ms. Cullivan’s decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Board greatly appreciates Ms. Cullivan’s deep commitment, leadership and many contributions to the Board and to the Company’s growth and progress during her years of service.
Read the 8-K filing - Sep 2, 2025
On August 28, 2025, Todd Morgenfeld was appointed to the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) effective immediately. The Board also appointed him to serve on the Audit Committee and Mergers and Acquisitions and Capital Structure Committee, commencing concurrently with his Board service. Mr. Morgenfeld is an independent director, with an initial term expiring at the Company’s 2026 annual meeting of stockholders. In connection with Mr. Morgenfeld’s appointment, the Board increased the number of directors on the Board from ten to eleven. Compensation for Mr.
Read the 8-K filing - May 13, 2024
On May 10, 2024, Axon Enterprise, Inc. (the “Company”) held its 2024 Annual Meeting of Shareholders (the “Annual Meeting”), at which the Company’s shareholders approved an amendment and restatement of the Company 2022 Stock Incentive Plan (the “Amended Plan”), the Company 2024 eXponential Stock Plan (the “2024 Employee XSP”) and the CEO Performance Award (the “2024 CEO Performance Award”). Please see
Read the 8-K filing - Mar 5, 2024
On March 4, 2024, the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) accepted Mark W. Kroll, Ph.D.’s resignation from the Board, effective as of the date of the Company’s 2024 Annual Meeting of Shareholders. The Board greatly appreciates Dr. Kroll’s deep commitment, leadership and many contributions to the Board and to the Company’s growth and progress during his years of service.
Read the 8-K filing - Dec 14, 2023
Employment Agreement with Patrick W. Smith On December 8, 2023, Axon Enterprise, Inc. (the “Company”) entered into an employment agreement (the “Employment Agreement”) with Patrick W. Smith, Chief Executive Officer of the Company. Under the Employment Agreement, Mr. Smith will continue to serve as the Company’s Chief Executive Officer and remain a member of the Company’s Board of Directors (the “Board”). The Employment Agreement provides the specific terms and conditions of Mr. Smith’s employment through December 31, 2030 and provides for at-will employment for an indefinite period thereafter. The Employment Agreement generally provides for compensation opportunities to Mr.
Read the 8-K filing - Sep 8, 2023
On September 7, 2023, the Compensation Committee approved revised executive compensation packages for Mr. Isner and Ms. Bagley, in connection with their previously announced promotions to President and Chief Operating Officer and Chief Financial Officer, respectively. Changes to annual base salary and annual target cash incentive compensation are effective as of July 1, 2023. The changes are consistent with the Compensation Committee’s compensation philosophy to generally set executive compensation at approximately the 50% benchmark to peers. In connection with his promotion, Mr. Isner will receive an annual base salary of $500,000. He will be eligible for annual target cash incentive compensation of $500,000. He will also be eligible for service-based and performance-based restricted stock units (“RSUs”) totaling a target of $11.32 million annually.
Read the 8-K filing - Jul 5, 2023
On June 28, 2023, Axon Enterprise, Inc. (the “Company”) promoted Joshua M. Isner to President, effective immediately. Mr. Isner, age 37, has been the Company’s Chief Operating Officer since May 2022, and previously held a number of roles at the Company since 2009, including the role of Chief Revenue Officer from January 2018 to May 2022. As President, Mr. Isner will continue to be responsible for Axon’s execution and driving its growth — including top line execution and global expansion into new markets and new product categories — and managing other day-to-day functions. Mr. Isner will continue to report to CEO and Founder Rick Smith. As Chief Revenue Officer, Mr. Isner was responsible for Axon’s global growth, customer service, professional services, and sales operations.
Read the 8-K filing - Mar 15, 2023
Election of Directors; Appointment of Principal Officers On March 10, 2023, Graham Smith and Jeri Williams were appointed to the Board of Directors of Axon Enterprise, Inc. (the "Company") effective March 16, 2023. Additionally, on March 14, 2023 Erika Ayers was appointed to the Board of Directors of the Company, effective June 1, 2023. Compensation for Ms. Ayers, Mr. Smith and Ms. Williams will consist of initial restricted stock unit awards with a grant date fair value of $200,000 vesting annually over three years, an annual restricted stock unit award which vests in one year with a grant date fair value of $200,000, and annual cash compensation of $40,000, paid quarterly. This is consistent with the current compensation program for the Board of Directors. There are no arrangements or understandings between Ms. Ayers, Mr. Smith or Ms.
Read the 8-K filing - Dec 14, 2022
On December 14, 2022, Axon Enterprise, Inc. (the “Company”) announced that Luke S. Larson, the Company’s President, will be returning from medical leave and effective December 31, 2022 will transition from the role of President to strategic advisor. The Company announced on May 26, 2022 that Mr. Larson had begun a medical leave of absence due to a serious, treatable health issue and that Joshua M. Isner had been promoted to Chief Operating Officer. While serving in his new non-officer capacity at Axon, Mr. Larson will be advising the company on its growth initiatives. “Luke’s contributions to the success of Axon’s entire business cannot be overstated, including having helped us to establish and grow our software and sensor business from an idea to the global market leading position we enjoy today,” Axon Chief Executive Officer Rick Smith said.
Read the 8-K filing - Aug 10, 2022
On August 10, 2022, Axon Enterprise, Inc. (the “Company”) issued a press release announcing the appointment of Brittany Bagley to serve as Chief Financial Officer and Chief Business Officer, effective September 26, 2022. Ms. Bagley will also be designated as the Company's Principal Financial and Accounting Officer. Ms. Bagley succeeds Interim Chief Financial Officer James C. Zito. Mr. Zito will continue in his position as Senior Vice President of Accounting. Ms. Bagley, 39, is joining the Company’s management team after serving as Chief Financial Officer of Sonos, Inc. since April 2019. Ms. Bagley also served on the Board of Directors of Sonos, Inc. from September 2017 to April 2019. From December 2017 to April 2019, Ms. Bagley served as a Managing Director of Kohlberg Kravis Roberts & Co. L.P.
Read the 8-K filing - Jun 2, 2022
On May 26, 2022, Axon Enterprise, Inc. (the “Company”) promoted Joshua M. Isner to Chief Operating Officer, effective immediately. Mr. Isner, age 36, has been the Company’s Chief Revenue Officer since January 2018, and previously held a number of roles at the Company since 2009. Luke S. Larson, the Company’s President, has begun a medical leave of absence due to a serious, treatable health issue that arose in recent weeks. Mr. Isner will assume Mr. Larson’s responsibilities going forward. As Chief Revenue Officer, Mr. Isner was responsible for Axon’s global growth, customer service, professional services, and sales operations. He joined Axon in 2009 as a member of the Leadership Development Program, and after rotating through several departments in the company, he eventually helmed and led the domestic video and cloud sales team to a record year in 2014.
Read the 8-K filing - May 4, 2022
On May 4, 2022, Axon Enterprise, Inc. (the “Company”) announced that Jawad A. Ahsan would be resigning as Chief Financial Officer (“CFO”), effective immediately, to pursue other opportunities. The Company’s board of directors has initiated a search to identify a permanent CFO and Mr. Ahsan will be available to the Company to support a smooth transition. As of the same date, the Company appointed Jim Zito as interim CFO, effective immediately. Mr. Zito, age 41, has been with the Company since 2017 and currently serves as the Company’s Senior Vice President of Accounting and corporate controller. As Senior Vice President of Accounting, Mr. Zito leads the Company’s global accounting and controllership organization. Prior to joining the Company in 2017, Mr.
Read the 8-K filing - Jan 31, 2022
On January 25, 2022, the Board of Directors of Axon Enterprise, Inc. (“Axon” or the “Company”) accepted the resignation of Dr. Richard H. Carmona for his retirement from the Axon Board effective the date of Axon’s next annual shareholder meeting, which is expected to occur in late May 2022. Dr. Carmona submitted his resignation pursuant to the Company’s governance guidelines for director tenure, having served on the Board since 2007. Dr. Carmona currently serves on our Scientific and Medical Committee and as the chair of our Nominating and Corporate Governance Committee. Dr. Carmona’s resignation was not a result of a disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Read the 8-K filing
Show 16 older changes
- Jun 3, 2020
On May 30, 2020, Adriane Brown was appointed to the Board of Directors of Axon Enterprise, Inc. (the "Company") effective immediately. Compensation for Ms. Brown will consist of an initial restricted stock unit award effective June 1, 2020 with the grant date fair value of $160,000 vesting annually over three years, an annual restricted stock unit award with a grant date fair value of $160,000 vesting annually over three years, and annual cash compensation of $36,000, paid quarterly. This is consistent with the current compensation program for the Board of Directors. There are no arrangements or understandings between Ms. Brown and any other persons pursuant to which Ms. Brown was selected as a director, and there are no transactions in which Ms. Brown has an interest requiring disclosure under Item 404(a) of Regulation S-K. Ms.
Read the 8-K filing - Jan 16, 2020
On January 4, 2020, the Compensation Committee of the Board of Directors of Axon Enterprise, Inc. (the "Company") approved a special incentive bonus for Mr. Joshua M. Isner, the Company's Chief Revenue Officer. In lieu of a cash bonus, Mr. Isner elected to receive a vehicle and a related tax gross-up payment totaling approximately $470,000; of the total amount, approximately 40% related to the tax gross-up payment. Mr. Isner received the vehicle in January 2020.
Read the 8-K filing - Aug 28, 2019
On August 23, 2019, Caitlin Elizabeth Kalinowski was appointed to the Board of Directors of Axon Enterprise, Inc. (the "Company") effective immediately. Compensation for Ms. Kalinowski will consist of an initial restricted stock unit award effective within ten days of her appointment to the Board with the grant date fair value of $160,000 vesting annually over three years, an annual restricted stock unit award with a grant date fair value of $160,000 with vesting over three years, and annual cash compensation of $36,000, paid quarterly. This is consistent with the Board of Directors compensation program effective as of May 25, 2017. There are no arrangements or understandings between Ms. Kalinowski and any other persons pursuant to which Ms. Kalinowski was selected as a director, and there are no transactions in which Ms.
Read the 8-K filing - Jun 14, 2019
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On June 13, 2019, Bret S. Taylor tendered his notice of retirement as a director of our company effective June 14, 2019. Mr. Taylor currently serves on our Mergers and Acquisitions Committee and as the chair of our Technology Committee. Mr. Taylor’s board service was instrumental over the past five years as Axon built its Evidence.com software-as-a-service business with a growing customer base. His resignation is not due to any disagreements with Axon on any operations, policies or practices. A copy of Mr. Taylor's resignation letter is attached as Exhibit 99.1 to this Current Report on Form 8-K. We sincerely thank Mr.
Read the 8-K filing - Jun 4, 2019
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On May 31, 2019 Axon Enterprise, Inc. (the “Company”) entered into new executive employment agreements (each, an “Agreement” and, collectively, the “Agreements”) with Luke S. Larson, President, Jawad A. Ahsan, Chief Financial Officer, and Joshua M. Isner, Chief Revenue Officer (each, an “Executive” and, collectively, the “Executives”).
Read the 8-K filing - Aug 22, 2018
On August 20, 2018, Douglas E. Klint, Executive Vice President, Corporate Secretary and former General Counsel of Axon Enterprise, Inc. (the "Company") and a named executive officer of the Company, submitted his resignation as an Executive Vice President as part of his retirement transition, which resignation was accepted by the Company’s board of directors. Mr. Klint will remain with the Company as Corporate Secretary for an unspecified period of time to provide for a successful transition of his duties to his successor.
Read the 8-K filing - May 24, 2018
CEO Performance Award As indicated below, at the 2018 Annual Meeting of the Stockholders (the “Meeting”) of Axon Enterprise, Inc. (the “Company”), the Company’s stockholders approved the CEO Performance Award for Patrick W. Smith. The CEO Performance Award consists of a grant of non-qualified stock options consisting of shares of common stock totaling 6,365,856 shares, carrying a term of ten years, that vests in 12 equal tranches. Each of the 12 tranches vests if, and only if, one market capitalization goal and one operational goal are attained. The material features of the CEO Performance Award are described in the Company’s definitive Proxy Statement on Schedule 14A, dated April 13, 2018 (the “Proxy Statement”), an excerpt of which description is filed herewith as Exhibit 99.1 and incorporated herein by reference.
Read the 8-K filing - Dec 4, 2017
The Company’s historic Section 16 Executive Officer employment agreements provided for 12 months’ notice and 12 months’ base salary as severance in the event of termination of the executive’s employment without cause, among other provisions. Some executive employment agreements, e.g. the Executive Employment Agreement for Rick Smith, the Company’s CEO, date back over 15 years ago. The Company determined that it was in the best interest of the Company’s stockholders to eliminate severance benefits for termination with cause, and to reduce severance benefits for termination without cause or for good reason from 12 months to 1 month of base salary, as well as to reduce the notice period from 12 months to 11 months.
Read the 8-K filing - Jul 25, 2017
On July 19, 2017, Julie Anne Cullivan was appointed to the Board of Directors of Axon Enterprise, Inc. (the "Company") effective immediately. Compensation for Ms. Cullivan will consist of an initial restricted stock award effective upon her appointment to the Board with the grant date fair value of $160,000 vesting annually over three years, annual restricted stock-incentive award with a grant date fair value of $160,000 with vesting over three years, and annual cash compensation of $36,000, paid quarterly. This is consistent with the Board of Directors compensation program effective as of May 25, 2017. Ms. Cullivan is expected to be appointed to the Company's Audit Committee. There are no arrangements or understandings between Ms. Cullivan and any other persons pursuant to which Ms. Cullivan was selected as a director, and there are no transactions in which Ms.
Read the 8-K filing - May 26, 2017
On May 24, 2017, a mutual decision was made to transition Marcus Womack, currently EVP and General Manager of the Software and Sensors business unit, to an advisory role on international matters. As such, Mr. Womack will no longer serve as an executive officer of the Company. The Company is currently negotiating, and anticipates entering into, an employment agreement with Mr. Womack to define the terms, conditions, duration and parameters of his employment relationship with the Company going forward.
Read the 8-K filing - Mar 23, 2017
On March 23, 2017, TASER International, Inc. (the “Company”) issued a press release announcing the appointment of Jawad A. Ahsan to serve as Chief Financial Officer. Mr. Ahsan will also be designated as the Company's Principal Financial and Accounting Officer. Mr. Ahsan succeeds Dan Behrendt and acting Chief Financial Officer Marie Masenga. Ms. Masenga will continue in her position as Corporate Controller. Mr. Ahsan, 38, is joining the Company's management team after serving, since May of 2014, as CFO for Market Track. Before joining Market Track, Mr. Ahsan had a 13-year career at General Electric Company where he served as CFO of Clinical Business Solutions, a division of GE Healthcare IT. Prior to this appointment, he served as CFO for Healthcare Knowledge & Connectivity Solutions, which he helped guide to an exit into Caradigm, GE’s healthcare IT joint venture with Microsoft. Mr.
Read the 8-K filing - Mar 1, 2017
SIGNATURE Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers In January 2017, Dan Behrendt, the Company's Chief Financial Officer, was severely injured when struck by a vehicle while riding his bicycle. Although Mr. Behrendt is recovering from his injuries, on February 28, 2017, the Company's Board of Directors passed a resolution appointing Marie Masenga, Corporate Controller, to be the Company's acting Principal Financial and Accounting Officer. Ms. Masenga, age 31, joined the Company in June 2016. Prior to joining the Company, Ms. Masenga served as the controller for a consulting firm headquartered in McLean, Virginia, for over four years. Before that, Ms. Masenga served as an accounting manager for a large publicly traded real estate investment trust in Phoenix, Arizona. Ms.
Read the 8-K filing - Nov 9, 2016
On November 9, 2016, TASER International, Inc. (the “Company”) announced it is commencing a search for a new Chief Financial Officer (“CFO”). Daniel M. Behrendt, the Company’s current CFO, will remain with the Company is his current capacity through the filing of the Company’s 2016 Form 10-K. Upon his separation from the Company, Mr. Behrendt will receive the benefits to which he is entitled pursuant to his executive employment agreement, which include two years of base salary and estimated bonus as well as the acceleration of certain restricted stock units. The total estimated severance amounts to approximately $1.5 million.
Read the 8-K filing - Oct 12, 2016
On October 5, 2016, Dr. Matthew R. McBrady, age 46, was re-appointed to the Board of Directors of TASER International, Inc. ("the Company") effective immediately. Dr. McBrady previously served as a director for the Company from January 2001 through June 2014. There are no arrangements or understandings between Dr. McBrady and any other persons pursuant to which Dr. McBrady was selected as a director. Compensation for Dr. McBrady consists of an initial restricted stock award with the grant date fair value of $100,000 vesting annually over 4 years, annual restricted stock-incentive award with a grant date fair value of $80,000 with vesting over 3 years and annual cash compensation of $35,000. This is consistent with the Board of Directors compensation program effective for 2016. Dr.
Read the 8-K filing - May 27, 2016
As indicated below, at the 2016 Annual Meeting of the Stockholders (the “Meeting”) of TASER International, Inc. (the “Company”), the Company’s stockholders approved the adoption of the Company’s 2016 Stock Incentive Plan (the “Plan”). The material features of the Plan are described in the Company’s definitive Proxy Statement on Schedule 14A, dated April 15, 2016 (the “Proxy Statement”), which description is filed herewith as Exhibit 99.1 and incorporated herein by reference. The above and the incorporated description of the Plan are qualified in their entirety by the text of the Plan, a copy of which is filed herewith as Exhibit 10.1 and incorporated herein by reference.
Read the 8-K filing - Jan 22, 2016
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing
Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021
Share price
Annual financials
From the company's 10-K XBRL data (SEC companyfacts).
| Fiscal year | Revenue | Net income | Margin | Diluted EPS | Total assets |
|---|---|---|---|---|---|
| FY2025 | $2.8B | $124.7M | 4.5% | $1.51 | $7.0B |
| FY2024 | $2.1B | $377.0M | 18.1% | $4.80 | $4.5B |
| FY2023 | $1.6B | $175.8M | 11.3% | $2.33 | $3.6B |
| FY2022 | $1.2B | $146.9M | 12.4% | $2.03 | $2.9B |
| FY2021 | $863.4M | -$60.0M | -7.0% | $-0.91 | $1.7B |
| FY2020 | $681.0M | -$1.7M | -0.3% | $-0.03 | $1.4B |
| FY2019 | $530.9M | $882K | 0.2% | $0.01 | $845.6M |
| FY2018 | $420.1M | $29.2M | 7.0% | $0.50 | $732.0M |
Former directors and officers (13)
People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.